$KONEF News

Last published 4y ago

4y agoKONEFWellbeing Digital Sciences Delivers its First IV Ketamine Treatment Under the Inpatient KITE ProgramGlobeNewswireVANCOUVER, British Columbia, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artif
4y agoKONEFWellbeing Digital Sciences Reveals Recent Achievements by Its KGK Science SubsidiaryGlobeNewswireVANCOUVER, British Columbia, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artif
4y agoKONEF NMLSFWellbeing Digital Sciences' Subsidiary KGK Science Forms Tactical Partnership with Nova MentisGlobeNewswireVANCOUVER, British Columbia, Jan. 27, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artifi
4y agoKONEFKetamine One Changes Name to Wellbeing Digital SciencesGlobeNewswireVANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), an evidence-based healthcare company focused on innovative clinical solutions, artifi
4y agoKONEFKetamine One Becomes Exclusive Ketamine Treatment Provider to Victoria WellnessGlobeNewswireVANCOUVER, British Columbia, Jan. 17, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
4y agoKONEFKetamine One Begins Trading on the OTCQB Marketplace on January 12, 2022GlobeNewswireVANCOUVER, British Columbia, Jan. 12, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTCQB:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American le
4y agoKONEFKetamine One Appoints Two New Members to Its Medical Advisory BoardGlobeNewswireVANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
4y agoKONEFKetamine One Announces 2021 AGSM ResultsGlobeNewswireVANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: MY0), a company focused on consolidating medical clinics and becoming a North American leader in
4y agoCGNSF KONEFKetamine One Reports Strong 1Q22 Financial ResultsGlobeNewswireVANCOUVER, British Columbia, Dec. 16, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
4y agoKONEFKetamine One Announces Lifting of Management Cease Trade OrderGlobeNewswireVANCOUVER, British Columbia, Dec. 15, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
4y agoKONEFKetamine One Appoints Joe Ramelli as Its New Chief Financial OfficerGlobeNewswireVANCOUVER, British Columbia, Dec. 14, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
4y agoCGNSF KONEFKetamine One Reports Audited Financial Results for the 2021 Fiscal YearGlobeNewswireVANCOUVER, British Columbia, Dec. 13, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
4y agoKONEFKetamineOne Adds Seattle Location to US Clinical NetworkGlobeNewswireVANCOUVER, British Columbia, Dec. 08, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: MY0), a company focused on consolidating medical clinics and becoming a North American leader in
4y agoKONEFKetamineOne Subsidiary KGK Science Helps Client Receive New Dietary Ingredient Status from U.S. FDAGlobeNewswireVANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: MY0), a company focused on consolidating medical clinics and becoming a North American leader in
4y agoCGNSF KONEFKetamine One Partners with Cognetivity Neurosciences in Collaborative Clinical Study on Depression and PTSDGlobeNewswireVANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: 6FC), a company focused on consolidating medical clinics and becoming a North American leader in
4y agoKONEFKetamine One Provides Second Update on Management Cease Trade OrderGlobeNewswireVANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: 6FC), a company focused on consolidating medical clinics and becoming a North American leader in
4y agoKONEFKetamine One Subsidiary IRP Health Opens Two New Veteran-Focused ClinicsGlobeNewswireVANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: 6FC), a company focused on consolidating medical clinics and becoming a North American lead
4y agoKONEFKetamine One Provides Update on Management Cease Trade OrderGlobeNewswireVANCOUVER, British Columbia, Nov. 15, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: 6FC), a company focused on consolidating medical clinics and becoming a North American leader in
5y agoKONEFKetamine One Announces Intention to Submit Draft Registration Statement for Proposed U.S. Initial Public OfferingGlobeNewswireDirector Steven Inglefield Has Also Been Appointed Chief Operating Officer of the Company VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt
5y agoKONEFKetamine One Announces Resignation of Loreto Grimaldi From Board of DirectorsGlobeNewswireVANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: 6FC), a company focused on consolidating medical clinics and becoming a North American leader in
5y agoKONEFKetamine One Announces Virtual Mental Healthcare Platform in Partnership With iHealthOXGlobeNewswireVANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (FRA: 6FC), a company focused on consolidating medical clinics and becoming a North American leader in
5y agoKONEFKetamine One Announces Late Filing of Annual Financial Statements and Management Cease Trade OrderGlobeNewswireVANCOUVER, British Columbia, Nov. 01, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: 6FC), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Provides Updated Information for Stock Exchange ListingsGlobeNewswireVANCOUVER, British Columbia, Oct. 21, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: 6FC), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Features Biostrap as Part of Inaugural Research StudiesGlobeNewswireVANCOUVER, British Columbia, Oct. 20, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Launching Two Inaugural Research StudiesGlobeNewswireVANCOUVER, British Columbia, Oct. 14, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoEHVVF KONEFEhave Hires Contract Research Organization To Conduct Ketamine Clinical Trial In Miami, FloridaGlobeNewswireMIAMI, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC:EHVVF) (the "Company"), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has hired KGK Science Inc., a contract research organization (CRO) t
5y agoKONEFKetamine One Subsidiary KGK Science Contracted to Support a Ketamine Clinical Trial in the United StatesGlobeNewswireVANCOUVER, British Columbia, Oct. 06, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Engages Integral Wealth as Its Market-MakerGlobeNewswireVANCOUVER, British Columbia, Sept. 24, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lea
5y agoKONEFKetamine One Signs LOI with Veteran Services USA to Open Therapy CenterGlobeNewswireVANCOUVER, British Columbia, Sept. 21, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lea
5y agoKONEFKetamine One Engages Psychology & Counselling Services Group for IRP HealthGlobeNewswireVANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lea
5y agoKONEFKetamine One Signs LOI for Two Ketamine Infusion Clinics in TexasGlobeNewswireVANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lea
5y agoCGNSF KONEFKetamine One to Deploy Cognetivity's Integrated Cognitive Assessment ToolGlobeNewswireVANCOUVER, British Columbia, Sept. 01, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lea
5y agoKONEFKetamine One Subsidiary IRP Health Expands With New Veteran-Focused ClinicsGlobeNewswireVANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Establishes Medical Advisory BoardGlobeNewswireVANCOUVER, British Columbia, Aug. 23, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Subsidiary KGK Science Secures Multiple New ContractsGlobeNewswireVANCOUVER, British Columbia, Aug. 16, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Advances Research Capabilities via Controlled Substance Dealers Licence ApplicationGlobeNewswireVANCOUVER, British Columbia, July 28, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One's IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransGlobeNewswireVANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Announces Adam Deffett as Interim CEOGlobeNewswireVANCOUVER, British Columbia, July 07, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Engages Various Providers of Investor Relations and Media ServicesGlobeNewswireVANCOUVER, British Columbia, June 18, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Highlights Psychedelic Research and Announces New Clinical TrialGlobeNewswireVANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Closes Previously Announced Acquisition of Integrated Rehab and PerformanceGlobeNewswireVANCOUVER, British Columbia, June 15, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead
5y agoKONEFKetamine One Appoints Loreto Grimaldi to Board of DirectorsGlobeNewswireVANCOUVER, British Columbia, June 14, 2021 (GLOBE NEWSWIRE) -- KetamineOne Capital Limited ("Ketamine One" or the "Company") (NEO: MEDI) (OTC:KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American lead